Enter assignee name

Trademarks = 11

Forward Citations = 33

Loading Chart...

6 inventors (with patents filed for the assignee):

Emmanuel John Simons (13 out of 13 patents)

Robert Ng (8 out of 8 patents)

Ellen Reisinger (5 out of 5 patents)

4. Sebastian Kügler (5 out of 5 patents)

5. Hanan Al-Moyed (5 out of 5 patents)

6. Michael J McKenna (4 out of 18 patents)

13 patents: Sort by Forward Citations

1. 12365726 - Anti-VEGF antibody constructs (2025-07-22),

2. 12305191 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2025-05-20),

3. 12275960 - AAV-mediated delivery of therapeutic antibodies to the inner ear (2025-04-14),

4. 12264317 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2025-04-01),

5. 12226493 - Methods of treating non-syndromic sensorineural hearing loss (2025-02-18),

6. 12077783 - AAV-mediated delivery of antibodies to the inner ear (2024-09-03),

7. 12077773 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2024-09-03),

8. 12071627 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2024-08-27),

9. 11993777 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2024-05-28),

10. 11807867 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2023-11-07),

11. 11781145 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2023-10-10),

12. 11697801 - AAV-mediated delivery of therapeutic antibodies to the inner ear (2023-07-11),

13. 11525139 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2022-12-13),

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, or preserve hearing. The company was founded in 2014 and is based in Boston, Massachusetts. Akouos is focused on harnessing the power of adeno-associated viruses (AAVs) to deliver gene therapies to treat hereditary hearing loss and related conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

13 Patents

#160 in Boston, MA

#1,400 in Massachusetts

#23,162 in US

#43,713 in the World

Boston, MA, United States of America

Akouos, Inc.